Now online in Cancer Discovery: Early Changes in Tumor-naive Cell-free Methylomes & Fragmentomes Predict Outcomes in Pembrolizumab-treated Tumors - by Eric Stutheit-Zhao, Enrique Sanz-Garcia, Pugh Lab, Lillian Siu, and colleagues doi.org/10.1158/2159-8… Princess Margaret Cancer Centre Ontario Institute for Cancer Research (OICR) #liquidbiopsy

Finally happy to share our paper at Cancer Discovery tracking fragmentomics and methylation in plasma to predict IO outcomes. Great summary of my friend and first co-author Eric Stutheit-Zhao! Thanks to all the co-authors and specially to our senior authors Pugh Lab and Lillian Siu!

Very proud my mentor and friend Lillian Siu to be the new AACR president-elect. I am sure she will bring good things and growth to AACR as she has done to many of us over the years worldwide. Congratulations!

I was delighted to join AACR President Patricia M. LoRusso Phil Greenberg, AACR President-Elect Pat LoRusso, and President-Elect Designate Lillian Siu at the #AACR24 Board of Directors meeting. We thank our officers and board members for all they do to advance the AACR's mission.

Can a blood sample be used to predict patient outcomes to #cancer #immunotherapy drug pembrolizumab? Researchers Enrique Sanz-Garcia, Eric Stutheit-Zhao and Lillian Siu from Princess Margaret Cancer Centre Research investigate this in their new study. Read more > uhnresearch.ca/news/assessing…; doi.org/10.1158/2159-8…

🔴 Llega la entrega de la beca Princess Margaret Cancer Centre drug development fellowship program con el objetivo de formar investigadores de España, Francia y el Reino Unido en el Princess Margaret Cancer Centre Research de Toronto en terapia experimental e investigación traslacional.  #DíaCienciaCRIS24

Immune checkpoint blockers in pts with solid organ transplant and solid tumors. Potential treatm for some pts but limited activity for pts with SOT and 🫁cancer.1/3 have organ rejection within 2mo after treatment initiation.Thanks all authors! OncoAlert authors.elsevier.com/sd/article/S20…

Un encuentro maravilloso con una gran maestra de ceremonias 🧡. Una tarde inolvidable… #NazaretOporto #150aniversario

Congratulations to Dr. Lillian L. Siu, Pioneer in Immuno-Oncology and Precision Medicine, Receives 2024 David A. Karnofsky Award #ASCO24 dailynews.ascopubs.org/do/dr-lillian-…

Shout-out to our 🇨🇦 cancer rock star, Lillian Siu - the recipient of ASCO #ASCO24 David Karnofsky Award🥇 A well-deserved recognition for her remarkable scientific contribution & for mentoring a generation of ⭐️ clinician-scientists 👏 🌎 Congratulations Lillian!

Honoured to pose with ASCO CEO at the end of the opening plenary and with the 🍁 crowd from Princess Margaret Cancer Centre and friends

Arguably the best #highlight of #ASCO24 is the Princess Margaret Cancer Centre 🇨🇦#DrugDevelopmentProgram #alumni get-together! Congrats and thankful to Lillian Siu for years of exceptional #mentorship grooming #leaders of #oncology worldwide 🌎😊 Ben Tran ChenLee Tom Wei-Wu Chen Natalie Cook 💙

Congratulations for your amazing PhD dissertation and a pleasure to join virtually from Toronto. You should be very proud as well as your mentors AnaOaknin MD PhD and Stephanie Lheureux !

Congrats Lillian Siu and all the team for this interesting paper! International Society of Liquid Biopsy Cancer Discovery AACR

Can we democratize #PrecisionOncology through accurate response prediction based solely on tumor H&E images🔬?? Our ENLIGHT-DeepPT framework can help make it happen! We are ecstatic to share our latest work in #DigitalPathology, just out in Nature Cancer! rdcu.be/dMB0u

#CCTG welcomes the most recent Practicum Participants to #YGK for a full day at our Central Offices with training in all aspects of cancer clinical trial conduct. #SolvingCancerTogether